ERBB2 and cancer: These nanoprobes were conjugated with anti-HER2 antibodies to target cancer cells specifically and were employed for both in vitro and in vivo fluorescence and magnetic resonance imaging, enabling the comprehensive and targeted imaging of breast cancer tumors [103].